Marmara University is exploring innovative methods to evaluate proprioception in patients with cervical radiculopathy, which often arises from cervical disc herniation. The clinical trial, listed on ClinicalTrials.gov, investigates the performance of the Pro-reach test in assessing upper extremity proprioception. While recruitment has not yet started, this study could have implications for diagnostic accuracy and therapeutic planning in neuromuscular disorders.
What is the trial about?
The study, sponsored by Marmara University, aims to assess upper extremity proprioception in patients diagnosed with cervical radiculopathy. Cervical radiculopathy is typically caused by cervical disc herniation, compressing nerve roots in the spinal column. This condition often leads to muscle weakness, pain, and reduced functional mobility. The trial will specifically focus on validating the Pro-reach test as an assessment tool for proprioception.
How does the Pro-reach test work?
The Pro-reach test analyzes proprioceptive capabilities—the body’s ability to sense and coordinate movement—of the upper limbs. Researchers will monitor how accurately participants can reach for predefined targets, measuring alignment and motor coordination. This approach could reveal deficiencies and aid in tailoring rehabilitation strategies for patients suffering from neuromuscular disorders like cervical radiculopathy.
What could be the future impact?
If successful, the clinical trial could standardize the Pro-reach test as a reliable diagnostic and therapeutic tool. Improved assessment methods could help clinicians identify proprioceptive impairments early and optimize intervention plans. Furthermore, the study may inform the medical device industry on the need for advanced diagnostic solutions tailored to specific neuromuscular conditions.
FAQ
- 1. Why is this clinical trial important?
- It seeks to improve patient outcomes by refining proprioception testing methodologies, potentially paving the way for better diagnostic standards in neurology and rehabilitation.
- 2. Has recruitment started?
- No, the trial is listed as “Not yet recruiting” as of now.
- 3. What patient population is included?
- The trial focuses on individuals diagnosed with cervical radiculopathy, typically associated with cervical disc herniation.
Conclusion
This innovative trial reflects ongoing efforts within the healthcare sector to address complex neuromuscular challenges. Diagnostic advancements, such as the Pro-reach test, underscore the role of specialized assessments in improving patient recovery trajectories and precision in clinical practices.
Disclaimer for professionals
This article is intended for informational purposes only. It does not constitute legal advice, regulatory guidance, or clinical recommendations. Please consult appropriate sources or regulatory authorities for definitive information.
Official trial link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07319156?term=medical+device